During this event, Sharon Pang is a panelist on “China: Mergers – Remedies retrospective.” The panel will cover what a successful remedy is, behavioural remedies, and when MOFCOM is willing to lift restrictions.
For more information, click here.
Navigating private equity in health care amid regulatory scrutiny
She joined Leslie C. Overton from Axinn Veltrop & Harkrider LLP and Rebekah Goshorn Jurata of the American Investment Council to discuss the growing antitrust...